We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$667M
AUM Growth
-$156M
Cap. Flow
+$83.2M
Cap. Flow %
12.47%
Top 10 Hldgs %
36.65%
Holding
203
New
66
Increased
38
Reduced
28
Closed
61

Sector Composition

Rank Sector Weight
1 Healthcare 23.53%
2 Miscellaneous 21.87%
3 Technology 20.83%
4 Utilities 9.14%
5 Materials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEGI
26
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$8.51M 1.28%
492,500
-212,500
-30% -$4.13M
MITL
27
DELISTED
Mitel Networks Corporation
MITL
$8.34M 1.25%
900,000
+465,000
+107% +$4.08M
CWEN.A
28
DELISTED
Clearway Energy Class A
CWEN.A
$8.33M 1.25%
505,849
-26,151
-5% -$452K
ESI icon
29
Element Solutions
ESI
$8.37B
$8.32M 1.25%
865,000
-160,000
-16% -$1.71M
AKAM icon
30
Akamai
AKAM
$15.3B
$7.81M 1.17%
+110,000
New +$7.49M
OEF icon
31
CALL
iShares S&P 100 ETF
OEF
$20.4B
$7.59M 1.14%
+50,000
New +$6.06M
OKTA icon
32
Okta
OKTA
$29.1B
$7.37M 1.1%
185,000
-106,500
-37% -$3.55M
ARCC icon
33
Ares Capital
ARCC
$14.2B
$7.14M 1.07%
+450,000
New +$7.13M
META icon
34
Meta Platforms (Facebook)
META
$1.65T
$7.03M 1.05%
+44,000
New +$7.9M
HDP
35
DELISTED
Hortonworks, Inc.
HDP
$7.01M 1.05%
345,000
-55,000
-14% -$1.08M
WAAS
36
DELISTED
AquaVenture Holdings Limited
WAAS
$6.75M 1.01%
543,425
+350,725
+182% +$4.92M
EEFT icon
37
Euronet Worldwide
EEFT
$2.7B
$6.71M 1.01%
+85,000
New +$7.48M
FOLD
38
DELISTED
Amicus Therapeutics
FOLD
$6.54M 0.98%
435,000
+105,000
+32% +$1.6M
UPLD icon
39
Upland Software
UPLD
$9.52M
$6.04M 0.91%
+21,000
New +$5.18M
AVGO icon
40
Broadcom
AVGO
$1.73T
$5.77M 0.87%
245,000
+205,000
+513% +$5.16M
TXMD icon
41
TherapeuticsMD
TXMD
$25M
$5.72M 0.86%
23,500
+2,500
+12% +$701K
CLVS
42
DELISTED
Clovis Oncology, Inc.
CLVS
$5.41M 0.81%
102,500
-2,000
-2% -$117K
NCLH icon
43
Norwegian Cruise Line
NCLH
$6.81B
$5.3M 0.79%
+100,000
New +$5.69M
ADMS
44
DELISTED
Adamas Pharmaceuticals
ADMS
$5.25M 0.79%
220,000
+65,000
+42% +$2.05M
APTI
45
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$5.24M 0.79%
185,000
-77,000
-29% -$2.06M
HCR
46
DELISTED
Hi-Crush Inc. Common Stock
HCR
$4.77M 0.71%
450,000
-120,000
-21% -$1.47M
SPY icon
47
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$4.74M 0.71%
+18,000
New +$4.91M
MU icon
48
Micron Technology
MU
$1.1T
$4.43M 0.66%
85,000
+67,000
+372% +$3.21M
IMMU
49
DELISTED
Immunomedics Inc
IMMU
$3.87M 0.58%
265,000
+40,000
+18% +$654K
SPWR
50
DELISTED
SunPower Corporation Common Stock
SPWR
$3.75M 0.56%
+717,690
New +$3.66M

Similar funds

Ardsley Advisory Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Ardsley Advisory Partners held 203 positions worth $667M, down 19% from $823M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ardsley Advisory Partners deployed $83.2M of net new capital in Q1 2018, opening 66 new positions and adding to 38 existing holdings. Its largest new stake was Celgene Corp: 224,500 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Macerich, an estimated $11.6M trimmed.

  • Ardsley Advisory Partners's largest Q1 2018 buy was Celgene Corp: 224,500 shares worth $20M.
  • Ardsley Advisory Partners added most to ProShares Trust UltraShort Lehman 20+ Year Treasury in Q1 2018, an estimated $42.5M increase.
  • Ardsley Advisory Partners's biggest Q1 2018 reduction was Macerich, cutting an estimated $11.6M.
  • Ardsley Advisory Partners fully exited AbbVie in Q1 2018, selling an estimated $20.1M.
  • Ardsley Advisory Partners's ten largest holdings make up 37% of its $667M portfolio in Q1 2018.
  • Ardsley Advisory Partners opened 66 new positions and closed 61 in Q1 2018.
  • Ardsley Advisory Partners's portfolio value fell 19% quarter-over-quarter to $667M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2018, filed 15 May 2018.